Pharma Journalist - Page 891 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Lyndra Raises $23 Million in Series A Financing to Advance Ultra-Long Acting Oral Therapeutic Delivery

Icon Bioscience Submits NDA for DEXYCU

BMS enters two separate agreement with Biogen and Roche

Transgene and Institut Bergonié Start the Phase 2 Part of the METROmaJX Trial

Streamline CDISC Electronic Data Submissions: Technology Solution for CDISC PK Study Data

1CellBiO Inc announces Collaboration Agreement with UCB

Kyorin acquired licenses from Merck for Investigational Therapy for Overactive Bladder in Asia

Neurocrine’s Ingrezza capsule approved to treat Tardive dyskinesia

OncoMed’s demcizumab fails to meet primary endpoint in pancreatic cancer trial

FDA approves two hepatitis C drugs for pediatric patients